Filing Details
- Accession Number:
- 0001415889-25-009295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-31 19:20:00
- Reporting Period:
- 2025-03-27
- Filing Date:
- 2025-03-31
- Accepted Time:
- 2025-03-31 19:20:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484565 | Soleno Therapeutics Inc | SLNO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422484 | H James Mackaness | 100 Marine Parkway, Suite 400 Redwood City CA 94065 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-27 | 1,669 | $65.97 | 124,129 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 2,717 | $66.79 | 121,412 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 4,940 | $67.70 | 116,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 6,498 | $68.79 | 109,974 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 3,762 | $69.84 | 106,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 387 | $70.73 | 105,825 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 563 | $71.74 | 105,262 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 86 | $72.64 | 105,176 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 20,000 | $30.75 | 125,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 10,000 | $5.10 | 135,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 5,000 | $2.60 | 140,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 15,000 | $2.41 | 155,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 20,000 | $5.25 | 175,176 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-27 | 25,799 | $69.07 | 149,377 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 36,157 | $70.03 | 113,220 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-27 | 8,044 | $70.80 | 105,176 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-27 | 20,000 | $0.00 | 20,000 | $30.75 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-27 | 10,000 | $0.00 | 10,000 | $5.10 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-27 | 5,000 | $0.00 | 5,000 | $2.60 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-27 | 15,000 | $0.00 | 15,000 | $2.41 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-27 | 20,000 | $0.00 | 20,000 | $5.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-11-16 | No | 4 | M | Direct | |
| 3,000 | 2032-01-28 | No | 4 | M | Direct | |
| 0 | 2032-07-27 | No | 4 | M | Direct | |
| 15,000 | 2033-01-25 | No | 4 | M | Direct | |
| 67,251 | 2033-05-26 | No | 4 | M | Direct |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $68.48 to $69.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $69.48 to $70.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $70.49 to $71.175. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.
- One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of January 1, 2022 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date.
- One forty-eighth of the shares subject to the option vest on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
- One thirty-sixth of the shares subject to the Option vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.
Billionaire Hedge Funds
